Basilea Pharmaceutica (XSWX:BSLN) Total Liabilities : CHF183.3 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica Total Liabilities?

Basilea Pharmaceutica's Total Liabilities for the quarter that ended in Dec. 2023 was CHF183.3 Mil.

Basilea Pharmaceutica's quarterly Total Liabilities declined from Dec. 2022 (CHF241.56 Mil) to Jun. 2023 (CHF215.05 Mil) and declined from Jun. 2023 (CHF215.05 Mil) to Dec. 2023 (CHF183.29 Mil).

Basilea Pharmaceutica's annual Total Liabilities declined from Dec. 2021 (CHF305.87 Mil) to Dec. 2022 (CHF241.56 Mil) and declined from Dec. 2022 (CHF241.56 Mil) to Dec. 2023 (CHF183.29 Mil).

Basilea Pharmaceutica Total Liabilities Historical Data

The historical data trend for Basilea Pharmaceutica's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica Total Liabilities Chart

Basilea Pharmaceutica Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

314.43

331.84

305.87

241.56

183.29

Basilea Pharmaceutica Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															305.87	303.24	241.56	215.05	183.29

Basilea Pharmaceutica Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Basilea Pharmaceutica's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	47.592	+	(111.091	+	24.608
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	183.3

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	173.289	-	-10.002
	=	183.3

Basilea Pharmaceutica's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	47.592	+	(111.091	+	24.608
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	183.3

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	173.289	-	-10.002
	=	183.3

Basilea Pharmaceutica Total Liabilities Related Terms

Thank you for viewing the detailed overview of Basilea Pharmaceutica's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Basilea Pharmaceutica (XSWX:BSLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (XSWX:BSLN) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BSLNz:UK

Address

Switzerland Innovation Park, Basel Area, Main Campus, Near Basel, Allschwil, CHE, 4058

Website

https://www.basilea.com

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica (XSWX:BSLN) Headlines

No Headlines